Gene Express, AbaStar, Castle Biosciences, University of Texas MD Anderson Cancer Center, National Cancer Institute, Institute for Systems Biology, Complete Genomics, Johns Hopkins, Rosetta Genomics | GenomeWeb
Gene Express, AbaStar to Collaborate on MDx Tests for Neurological Disorders
 
Gene Express this week said that it has signed a definitive agreement to collaborate with AbaStar MDx on the development of biomarker tests for neurological and psychological disorders.

Under the agreement, AbaStar has licensed Gene Express’ SEM Center and StaRT-PCR technology. It will combine the PCR technology with its own RNA biomarker signatures to develop diagnostic tests that run from a blood sample and provide results in a day.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.